2 Hrs
Source:
المشهد
17% Loss With New Pill
The anti-obesity drug Wegovy will arrive in French pharmacies on Monday in tablet form, becoming the first GLP-1 treatment to be offered orally in the country. It is available by prescription to adults with obesity, or who are overweight and have a weight-related condition. A study supporting its approval found an average weight loss of nearly 17% at the highest dose after about 15 months of treatment. The tablets should be taken in the morning on an empty stomach with a small amount of water, with a 30-minute wait before eating, drinking or taking other medication. They will cost between €169 and €235 per month and will not be covered by health insurance at launch.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)